ArticleBMC urology2025
Serum lactate Dehydrogenase-to-Albumin ratio in upper tract urothelial carcinoma: A promising prognostic biomarker.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this study is to assess the predictive significance of lactate dehydrogenase-to-albumin ratio (LAR) in patients with upper tract urothelial carcinoma (UTUC) who have undergone radical nephroureterectomy (RNU). MATERIALS AND
methodsWe performed a retrospective analysis on patients with UTUC at West China Hospital, covering the period from May 2003 to June 2019. The optimal cut point of LAR was determined using the X-Tile program. Relevant statistical methods included the utilization of Kaplan-Meier curves for survival estimation and the application of Cox proportional hazard model for risk evaluation. A nomogram was constructed to predict the 3-year and 5-year CSS and the predictive performance was also evaluated.
resultsA cohort of 577 patients with UTUC who underwent RNU were included in the study, and the threshold value of LAR was 5.07. LAR ≥ 5.07 was associated with worse CSS [hazard ratio (HR) = 1.72; 95% confidence interval (95%CI): 1.18-2.50; P = 0.005] in fully adjusted Cox regression analysis. In addition, the nomogram utilizing the LAR exhibited excellent prognostic performance in predicting CSS, with time-dependent areas under the curve (tAUC) values of 0.814 and 0.781 for 3-year and 5-year CSS, respectively.
conclusionPreoperative LAR could be regarded as a valuable individualized tool for clinical decision-making, as it independently predicts CSS in UTUC patients undergoing RNU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.